Braslyn is an investment fund managing more than $8.35 billion ran by Jason Callender. There are currently 2 companies in Mr. Callender’s portfolio. The largest investments include Inseego Corp and Tango Therapeutics Inc., together worth $8.35 billion.
As of 7th August 2024, Braslyn’s top holding is 761,483 shares of Inseego Corp currently worth over $8.12 billion and making up 97.2% of the portfolio value.
Relative to the number of outstanding shares of Inseego Corp, Braslyn owns less than approximately 0.1% of the company.
In addition, the fund holds 26,961 shares of Tango Therapeutics Inc. worth $231 million.
Currently, Braslyn's portfolio is worth at least $8.35 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Braslyn office and employees reside in Lyford Cay, New Providence, Bahamas. According to the last 13-F report filed with the SEC, Jason Callender serves as the Director at Braslyn.
The two most similar investment funds to Braslyn are Eclipse Ventures and Marathon Asset Management LL.P.. They manage $8.38 billion and $8.26 billion respectively.
Braslyn’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Technology — making up 97.2% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $113 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Inseego Corp |
No change
761,483
|
$8,117,409,000 | 97.23% |
| Tango Therapeutics Inc. |
No change
26,961
|
$231,325,000 | 2.77% |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||